Abstract:Melanoma is a malignant tumor with the highest growth dynamics in terms of the number of cases, simultaneously being the main cause of cancer-related deaths due to skin malignancies. [ 1 , 2 ] The incidence of melanoma is 10 to 25 new cases per 100,000 inhabitants; in the United States of America, it is 20 to 30 per 100,000; and in Australia, where a very high incidence is observed, it reaches 50 to 60 per 100,000. In recent years, there has been a dramatic increase in melanoma incidence among individuals over 60 years of age, especially in men. It is predicted that this upward trend will persist for the coming decades. [ 3 ] Melanoma cases in Poland are fewer than half of the European Union average. Nevertheless, despite the lower number of cases, Poland has one of the highest mortality rates in relation to incidence in Europe and reports more deaths due to melanoma. [ 4 ] Moreover, in Poland, around 1500 melanomas are detected each year at an advanced or metastatic stage. The most common phenotypic risk factor for melanoma is fair skin with a tendency to sunburn. Greater risk of developing this type of cancer also exists among individuals with a high number of pigmented lesions and large congenital and dysplastic nevi. Conversely, the most important exogenous factor is exposure to ultraviolet radiation. [ 5 ] Melanoma incidence also has a genetic basis, most commonly associated with familial atypical multiple mole melanoma syndrome. In this syndrome, mutations in the cyclin-dependent kinase inhibitor 2A gene, and less frequently in cyclin-dependent kinase 4 (CDK4), are often observed. Overall, up to 45% of genetically-caused melanomas are linked to known germline mutations in the cyclin-dependent kinase inhibitor 2A or CDK4 genes. [ 6 , 7 ] Furthermore, it has been shown that excessive exposure to ultraviolet radiation influences the genetic characteristics of melanomas. The mutation of the B-Raf protein gene in which valine (V) is substituted by glutamic acid (E) at amino acid 600 genotype is more common in patients who used tanning beds compared to those who never did, and it is also more prevalent in patients who started tanning before the age of 25 compared to those who started later in life. [ 8 ] Among Poles, fair skin complexion is predominant, significantly increasing the risk of melanoma development. Intensive preventive efforts can contribute to identifying this cancer in earlier stages of its progression, consequently leading to a reduction in melanoma-related deaths. Among preventive measures aimed at early melanoma detection, clinical examinations conducted by dermatologists and enhanced with dermoscopy are particularly important due to their widespread accessibility and effectiveness. Clinical diagnosis of melanoma is based on: visual examination of the entire body's skin, utilizing the ABCDE criteria (asymmetry, irregular border, uneven color, diameter > 6 mm, and evolution over time) to detect suspicious oncological pigmented lesions; a comparative analysis involving the search for a change that does not resemble others in the same patient and evaluating the development of pathological pigmented lesions based on available documentation. The sensitivity of clinical diagnosis performed by experienced dermatologists is estimated at around 70%. [ 9 ] Expanding the clinical examination with dermoscopy increases the accuracy of assessment, achieving a sensitivity of 89% and specificity of 79% in melanoma detection. [ 10 ] Dermoscopy should encompass all nevi, not just clinically suspicious ones, as it potentially allows for the detection of melanoma's morphological features before it becomes clinically recognizable. Numerous observational studies have shown that regular whole-body screening examinations conducted by physicians are associated with a decreased frequency of advanced-stage melanomas and reduced mortality due to them. [ 11–13 ] The aim of this study was to assess the prevalence of melanoma risk factors among residents of the Silesian Voivodeship and their knowledge regarding the diagnosis and prevention of this mentioned cancer.

Prevention of cancer—Melanoma development and its diagnosis among Silesian Voivodeship residents: Preliminary results

New Screening Methods in Melanoma

Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?

The incidence and clinical analysis of non-melanoma skin cancer

Melanoma Early Detection and Awareness: How Countries Developing Melanoma Awareness Programs Could Benefit from Melanoma-Proficient Countries.

Epidemiology of Melanoma

500pd new diagnostic techniques in early diagnosis of melanoma in situ

3 1 Epidemiology of Melanoma

Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management

Melanoma: Diagnosis and Treatment

Melanoma Detection by Non-Specialists: An Untapped Potential for Triage?

Impact of Patient's Age and Physician's Professional Background on the Number Needed to Treat in Malignant Melanoma Detection

Melanoma Epidemiology and Sun Exposure

Trends in the Diagnosis and Clinical Features of Melanoma in Situ (MIS) in US Men and Women: A Prospective, Observational Study

Impact of Melanoma Diagnosis on Sun-Awareness and Protection: Efficacy of Education Campaigns in a High-Risk Population

[The Rise of Artificial Intelligence - High Prediction Accuracy in Early Detection of Pigmented Melanoma]

Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions

Melanoma in Pregnancy—Diagnosis, Treatment, and Consequences for Fetal Development and the Maintenance of Pregnancy

The Role of Digital Dermoscopy and Follow-Up in the Detection of Amelanotic/Hypomelanotic Melanoma in a Group of High-Risk Patients—Is It Useful?

Patients poorly recognize lesions of concern that are malignant melanomas: is self-screening the correct advice?

P023 Real-world melanoma miss rate in an NHS hospital dermatology service